Hiroshi Kayakiri

Structure of FR 900482, a novel antitumor antibiotic from a Streptomyces

Itsuo Uchida, Shigehiro Takase, Hiroshi Kayakiri et al. · Journal of the American Chemical Society · 1987 · 155 citations

Pharmacy, Medicinal Chemistry, Microbiology +8

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B₂Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Yuki Sawada, Hiroshi Kayakiri, Yoshito Abe et al. · Journal of Medicinal Chemistry · 2004 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The identification of an orally active, nonpeptide bradykinin B₂ receptor antagonist, FR173657

Masayuki Asano, Noriaki Inamura, Chie Hatori et al. · British Journal of Pharmacology · 1997 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

A Novel Class of Orally Active Non-Peptide Bradykinin B₂ Receptor Antagonists. 1. Construction of the Basic Framework

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Probes for Narcotic Receptor Mediated Phenomena. 23. Synthesis, Opioid Receptor Binding, and Bioassay of the Highly Selective δ Agonist (+)-4-[(α<i>R</i>)-α-((2<i>S</i>,5<i>R</i>)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- <i>N</i>,<i>N</i>-diethylbenzamide (SNC 80) and Related Novel Nonpeptide δ Opioid Receptor Ligands

Silvia N. Calderon, Kenner C. Rice, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 1997 · 85 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16